What is Allergan Lap-Band Used For?
The Allergan LAP-BAND® System is an adjustable gastric banding device designed to treat obesity in adults. During a laparoscopic surgical procedure, a silicone band is placed around the upper portion of the stomach, creating a small pouch that limits how much food a person can comfortably consume at one time. The band connects to an access port implanted just beneath the skin, which a physician can use to inflate or deflate the band over time, theoretically customizing the restriction to the patient’s needs.
The device received FDA approval in 2001 and was marketed as a less invasive, adjustable, and reversible alternative to more permanent bariatric procedures such as gastric bypass or gastric sleeve surgery. Allergan promoted the Lap-Band as a safe, long-term weight loss solution, and it was implanted in hundreds of thousands of patients in the years following its approval.
However, independent medical research and mounting patient complaints painted a far more troubling picture. Studies published in peer-reviewed journals found that real-world complication and failure rates far exceeded the figures Allergan provided to the public and to the FDA. According to data compiled across multiple clinical studies, up to 50% of patients require full band removal within 10 years of implantation, and research published in JAMA Surgery found that nearly one-third of patients required revision surgeries within just five years. Allergan ultimately discontinued Lap-Band production and sold the rights to the technology, but the company’s legacy of alleged concealment and misleading marketing has continued to generate litigation.
Common Injuries Associated with Allergan Lap-Band Complications
The complications associated with the Allergan Lap-Band range from painful and disruptive to life-threatening. While Allergan acknowledged that some adverse events could occur, independent research consistently showed that serious injuries happened at rates far higher than the company disclosed. Patients who underwent Lap-Band surgery have reported the following complications:
The silicone band can shift from its surgically placed position around the upper stomach. When this happens, the stomach can slip upward through the band, blocking the normal passage of food and causing persistent nausea, uncontrollable vomiting, reflux, and an inability to eat. Slippage frequently requires emergency surgical intervention to reposition or remove the device.
Over time, the band can gradually wear through the stomach wall and erode into the stomach tissue itself. This process can cause infection, chronic pain, and — in severe cases — life-threatening conditions. Emergency surgical removal is typically required, and some patients sustain permanent digestive damage as a result.
The subcutaneous port used to adjust the band is a common source of complications. The port can flip, disconnect from its tubing, or become infected. Port infections can spread systemically and require hospitalization, antibiotics, and additional surgery to address.
The narrowed stomach opening created by the band can become completely blocked, making it impossible to consume even liquids. This constitutes a medical emergency requiring immediate intervention, including possible removal of the device.
Chronic restriction or improper band positioning can cause the esophagus to stretch abnormally over time. This leads to severe acid reflux, difficulty swallowing, and regurgitation. In many cases, esophageal dilation and its symptoms persist even after the band is removed, representing a permanent injury.
Many patients developed or experienced a significant worsening of GERD following Lap-Band implantation. Chronic heartburn, regurgitation, and acid damage to the esophageal lining have been reported, often requiring long-term medication management or additional surgical treatment.
The access port or connecting tubing can develop leaks, causing the band to lose pressure and become ineffective. In many cases, patients experienced undetected weight regain for months before the leak was identified, requiring another surgical procedure to repair or replace the device.
Because the Lap-Band severely restricts food and fluid intake, some patients experienced significant nutritional deficiencies and dehydration. These conditions can require hospitalization and have their own long-term health consequences.
In the most serious cases, Lap-Band complications have contributed to patient deaths, which have been the subject of lawsuits filed against Allergan and affiliated surgery providers.
How Are the Medical Device and Injuries Linked?
Plaintiffs and their medical experts contend that the injuries associated with the Allergan Lap-Band are not merely the unavoidable risks of any surgical procedure — they are the predictable consequence of a defectively designed device, substandard manufacturing practices, and a deliberate corporate decision to obscure the true scope of the risks.
Design Defects
The fundamental mechanics of the Lap-Band create conditions that predispose patients to the injuries described above. The silicone band exerts continuous pressure on stomach tissue over a period of years. That sustained pressure promotes the gradual erosion of the band through the stomach wall and creates ongoing mechanical stress that contributes to slippage. The access port system, integral to the device’s adjustability, has a documented history of failure through flipping, disconnection, and infection. Plaintiffs allege these are not isolated manufacturing problems but structural flaws inherent in the device’s design.
Concealment of Known Defects
In 2018, the United States Department of Justice announced that Allergan agreed to pay $3.5 million to resolve federal whistleblower allegations that the company knowingly sold Lap-Band devices with defective access ports between 2008 and 2010. According to federal prosecutors, Allergan misrepresented the cause of access port leaks to healthcare providers, patients, and the FDA — effectively concealing a known defect to prevent a drop in sales. The California Department of Insurance reached a separate $500,000 settlement with Allergan over similar conduct. The DOJ further alleged that Allergan marketed the device for procedures that were not FDA-approved, inducing physicians through sham advisory boards, speaking fees, and sponsored workshops.
Failure to Warn
Internal documents reviewed in connection with litigation suggest that Allergan was aware of complication rates considerably higher than those it publicly disclosed. Independent scientific studies published in respected journals — including Obesity Surgery and the Annals of Surgery — documented slippage rates, erosion rates, and reoperation rates that significantly exceeded Allergan’s own figures. Despite this evidence, Allergan continued promoting the Lap-Band as a safe, long-term solution without disclosing the realistic probability that patients would require additional surgeries, develop permanent injuries, or need the device removed entirely.
FDA Scrutiny
The FDA raised concerns about misleading Lap-Band advertising as early as 2011, directing weight-loss surgery centers to pull advertisements that “glamorized” the procedure without communicating its risks. The agency’s concern — that consumers were being influenced by marketing that failed to convey the realistic danger profile of the device — has proven prophetic in light of subsequent litigation and patient outcomes.
What are the Lawsuits About and Recent Litigation Updates?
The Core Legal Claims
Lawsuits against Allergan over the Lap-Band device center on four primary legal theories: defective design, failure to warn, negligent manufacturing, and fraudulent or misleading marketing.
- Defective Design Claims – Plaintiffs allege that the Lap-Band was brought to market with design characteristics that made harmful complications not merely possible, but likely over the course of normal use. The high rate at which bands slip, erode, and fail — documented in multiple independent studies — is central to these claims.
- Failure to Warn Claims – Patients and their physicians have a right to make informed decisions about surgical procedures. The lawsuits allege that Allergan deliberately understated the frequency and severity of known complications, depriving patients of the information they needed to give meaningful informed consent.
- Manufacturing Defect Claims – Some plaintiffs allege that quality control failures in the manufacturing process resulted in devices produced from substandard materials or with inconsistent specifications, increasing the risk of failure beyond even what the flawed design would otherwise produce.
- Fraudulent Marketing Claims – Allergan is accused of affirmatively misrepresenting the Lap-Band’s safety profile and efficacy while downplaying or concealing evidence of its dangers, prioritizing revenue over patient welfare.
Recent Litigation Developments
The litigation landscape surrounding the Allergan Lap-Band has evolved significantly over time. In 2018, Allergan settled federal and state government claims for a combined $4 million related to knowingly selling devices with defective access ports and misrepresenting the cause of failures to the FDA and healthcare providers. In January 2026, a federal district court in Maryland approved a settlement between Allergan and a whistleblower who had filed a False Claims Act suit alleging that Allergan provided surgeons with free advertising in exchange for their agreement to use the Lap-Band — a kickback scheme that, plaintiffs argued, further corrupted the flow of unbiased medical information to patients.
Allergan is now a subsidiary of AbbVie, following a 2020 acquisition. Allergan sold the Lap-Band technology rights and ceased production of the device. Civil litigation related to personal injuries caused by the device continues to be pursued, and attorneys who specialize in defective medical device mass torts are actively evaluating cases on behalf of injured patients. Given the complexity of identifying the responsible corporate entities and navigating applicable statutes of limitations, consulting with an experienced attorney promptly is essential.
Do You Qualify for a Allergan Lap-Band Lawsuit?
Not every patient who received a Lap-Band will have a viable legal claim. Patients may qualify to file an Allergan Lap-Band lawsuit if they meet certain criteria. To pursue a Lap-Band injury claim, potential claimants generally must meet the following criteria:
You underwent bariatric surgery in which an Allergan LAP-BAND® System was implanted for weight loss.
You suffered one or more recognized complications attributable to the device, including but not limited to band slippage, band erosion, access port failure or infection, stomach or esophageal obstruction, or esophageal dilation directly linked to the device.
Your complications necessitated a return to the operating room for revision surgery, repositioning of the band, surgical removal of the device, or other invasive treatment beyond your original procedure.
You incurred measurable harm as a result of your complications, which may include medical expenses (hospitalizations, additional surgeries, medications, ongoing treatment), lost income or reduced earning capacity, physical pain and suffering, or emotional distress.
Timing matters. Filing deadlines also vary by state and acting promptly helps preserve your legal rights and ensure that critical medical records and evidence are available. The nature and severity of your specific injury and the timing of your surgery will also factor into the evaluation. It’s important to contact a lawyer experienced in injuries related to defective medical devices as soon as possible to evaluate your legal options.
Contact Us Today
At LexLegal, we are committed to holding medical device manufacturers accountable for the harm caused by their defective products. We represent individuals and families who have suffered serious injuries from Allergan Lap-Band complications, and we are actively accepting new cases. Let us fight for you to hold the manufacturers accountable for your injuries and recover the compensation you deserve.
If you or someone you love underwent Allergan Lap-Band surgery and later experienced serious medical complications – bowel obstruction, band slippage, band erosion, a dangerous infection, or other serious injury, contact us today. We stand ready to assist you in pursuing fair compensation for your injuries to the fullest extent allowed under the law.
LexLegal offers free, confidential case evaluations to determine whether you qualify for an Allergan Lap-Band lawsuit. Complete our instant case evaluation form. We’ll review your information and promptly respond about your legal options. Every Allergan Lap-Band lawsuit we handle is taken on a contingency fee basis, which means there are no upfront costs for clients. Our firm is experienced in handling defective medical device cases, and we welcome any questions you may have.
Complete our instant case evaluation today to learn whether you may be eligible to file an Allergan Lap-Band lawsuit.
